Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Isotechnika Pharma Inc
IPHAF
Healthcare
Biotechnology
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IPHAF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(0)
•••
tcdrugs
X
View Profile
View Bullboard History
Post by
tcdrugs
on Jan 31, 2012 12:16pm
Looking for a more favorable agreement ?
You've got to be kidding. 3 weeks ago Iljin wanted to give you almost $18 M by purchasing shares at a 70% premium to the actual share price. That's not favorable to ISA
...more
(0)
•••
blog
X
View Profile
View Bullboard History
Comment by
blog
on Jan 31, 2012 12:04pm
RE: RE: Question is.....
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(48)
•••
ISAloser247
X
View Profile
View Bullboard History
Post by
ISAloser247
on Jan 31, 2012 11:12am
RE: Question is.....
......That is all there ever is with this mother******* company, Questions! NEVER ANY ANSWERS! UNRESOLVED ISSUES! Joint venture failures! Every year, for the
...more
(0)
•••
blog
X
View Profile
View Bullboard History
Post by
blog
on Jan 31, 2012 10:59am
ILJN left
Not the same stock price movment as when Roch left. The question remains can Isotechnika put a deal together for voclosporin or not.
(48)
•••
ISAloser247
X
View Profile
View Bullboard History
Post by
ISAloser247
on Jan 31, 2012 10:58am
TERMINATED!!!!! Iljin agreement
promising millions toward Phase 3 trial --- TERMINATED!!!!EVERYONE AT ISA SHOULD BE TERMINATED!!!!!!! HOW CAN THIS ******* SH** SHOW KEEP ON GOING IN THIS MANNER? T
...more
(48)
•••
ISAloser247
X
View Profile
View Bullboard History
Post by
ISAloser247
on Jan 30, 2012 5:02pm
JANUARY 28, 2012----SECOND DEVELOPMENT PAYMENT
---NO NEWS, NOTHING!!!!! According to the Iljin Life Science Co. Agreement, on or before the above date, IF the Joint Steering Commitee has determined 'satisfactorily advanced Phase 3
...more
(48)
•••
ISAloser247
X
View Profile
View Bullboard History
Post by
ISAloser247
on Jan 27, 2012 12:10pm
3 weeks and NOTHING!!!!!!!
NO NEWS! NO CLARIFICATION-!! The new year starts on GREAT, PROMISING NEWS of a major pharma interested in a possible new indication! BUT AS 'some individuals are
...more
(0)
•••
narcissist
X
View Profile
View Bullboard History
Post by
narcissist
on Jan 25, 2012 9:45am
Voclosporin and Kidney Transplantation
As far as i am aware - pending the initiation of a Phase 3 Clinical trial - there are no transplantation clinical studies currently underway in North America, other than the "Special Access for
...more
(0)
•••
narcissist
X
View Profile
View Bullboard History
Comment by
narcissist
on Jan 25, 2012 3:56am
Voclosporin and uveitis
There is not much news available on uveitus other than the fact that the application remains viable. LUX is still recruiting patients for a stage 3 clinical trial (study identifier NCT01243983). The
...more
(48)
•••
ISAloser247
X
View Profile
View Bullboard History
Post by
ISAloser247
on Jan 23, 2012 12:05pm
RE: strategic MUMBLES part 3 ......
LIES? georgie, that is quite the whopper about Dr. Peter Wijngarrd being the KAHUNA at Vifor! According to Reuters, he is the 'Vice President' , Innovation Leader
...more
(48)
•••
ISAloser247
X
View Profile
View Bullboard History
Post by
ISAloser247
on Jan 23, 2012 11:31am
RE:strategic MUMBLES, Part 2.......
Georgie, YOUR DD SUCKS!!!! you were on a roll, others, WHO OWN AND HAVE OWNED SHARES FOR YEARS, would KNOW that David Chen, did not have the 'BANDWIDTH" any longer, resigned as Business
...more
(48)
•••
ISAloser247
X
View Profile
View Bullboard History
Post by
ISAloser247
on Jan 23, 2012 11:13am
RE: 'strategic' MUMBLES..............
hey, Georgie, point out my lies! BY SUMMING UP YOUR DIAHERITICAL THESIS with 'mumbles something about confidentiality and possible strategic transactions' ONLY EMPHASIZES EVERYTHING THAT
...more
(0)
•••
Georgealphabeta
X
View Profile
View Bullboard History
Post by
Georgealphabeta
on Jan 22, 2012 8:35am
strategic transactions part 2
Let;s clear up certain misconceptions ( or should i say lies - hey Isaloser, please charge me in the law of court, by the way, Palladin is also invited). Palladin through stock manipulation brought
...more
(0)
•••
narcissist
X
View Profile
View Bullboard History
Post by
narcissist
on Jan 21, 2012 1:48am
Voclosporin and Lupus
While the market for transplant indications for calcineurin inhibitor drugs has been variously estimated at $3.3 billion, the recent arrangement with Vifor Pharma for lupus and all proteinuric
...more
(48)
•••
ISAloser247
X
View Profile
View Bullboard History
Post by
ISAloser247
on Jan 20, 2012 4:11pm
RE: invest in voclo-side effects, LOSE MONEY
...could not help but NOTICE, one of the MAJOR SIDE EFFECTS of voclosporin, has been the LOSS OF MONEY, wihout any benefits to any patients. Hoffman-Roche invests tens of millions, walks
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >